Dbv Technologies Announces Appointment of Virginie Boucinha As Chief Financial Officer

DBV Technologies , a clinical-stage biopharmaceutical company, today announced the appointment of Virginie Boucinha as its Chief Financial Officer, effective November 6, 2023. An experienced financial and operations executive, Virginie will report directly to Daniel Tassé, Chief Executive Officer, and serve as a member of the Executive Committee. Sébastien Robitaille, Chief Financial Officer, DBV Technologies, will be leaving the Company to pursue other opportunities on November 17 th . Virginie will onboard on November 6, 2023, allowing for a smooth two-week transition between executives.